Detected ·
DNAswitch
€500KOther
DNAswitch, a University of Padua spin-off developing gene therapy for Huntington disease, received a €500k investment from the newly launched BII Catalyst Fund for Italy I, managed by Panakes Partners.
- Website
- —
- linkedin.com/company/102314597
- Amount
- €500 000 EUR
- Stage
- Other
- Event
- Funding round
- Detected
- 2026-11-11 16:17:12 UTC
- Signal ID
- 7836df5a-9249-488d-96bb-c9a56161d9be
As the API returns it
{
"id": "7836df5a-9249-488d-96bb-c9a56161d9be",
"created_at": "2026-11-11T16:17:12.326314Z",
"company_name": "DNAswitch",
"company_website_url": null,
"company_linkedin_url": "https://www.linkedin.com/company/102314597",
"event_type": "funding",
"funding_amount": 500000,
"funding_currency": "EUR",
"funding_stage": "other",
"message": "*DNAswitch, a University of Padua spin-off developing gene therapy for Huntington disease, received a €500k investment from the newly launched BII Catalyst Fund for Italy I, managed by Panakes Partners.*"
}